tiprankstipranks
Trending News
More News >
Metro Inc. (TSE:MRU)
TSX:MRU

Metro Inc. (MRU) AI Stock Analysis

Compare
443 Followers

Top Page

TSE:MRU

Metro Inc.

(TSX:MRU)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
C$98.00
â–²(2.49% Upside)
The score is driven mainly by strong, stable financial performance and a constructive earnings outlook with continued investment and shareholder returns. These positives are tempered by clearly bearish technical signals and only moderate valuation support at a ~20.5 P/E with a ~1.63% yield.
Positive Factors
Steady revenue growth and stable margins
Consistent topline growth with near-20% gross margins and mid-single-digit net margins indicates resilient, repeatable grocery and pharmacy demand. This stability supports predictable earnings, operational planning and reinvestment over the medium term, reducing cyclicality risk.
Strong absolute cash generation
Substantial operating and free cash flow provide durable funding for capex, network investments, dividends and buybacks. High absolute cash generation enhances financial flexibility, enabling the company to fund growth initiatives and shareholder returns without relying solely on external financing.
Disciplined capital allocation and shareholder returns
A long track record of dividend increases plus active buybacks reflects management confidence in cash flows and disciplined capital priorities. This consistency supports investor trust, signals sustainable free cash deployment, and aligns incentives toward steady long-term value creation.
Negative Factors
Elevated and rising debt levels
An increase in total debt reduces balance sheet flexibility and raises interest exposure, constraining the company's ability to pursue opportunistic investments or absorb cost shocks. If margins compress or rates rise, higher leverage could force tradeoffs between growth, buybacks and dividends.
Weaker cash conversion and volatile FCF growth
Declining cash conversion and a turn to negative FCF growth signal lower earnings quality and less internally available capital. Over months this can limit reinvestment, slow rollout of initiatives, or increase reliance on borrowing, amplifying execution risk under higher leverage.
Pharmacy margin uncertainty from GLP-1 genericization
Earlier-than-expected generic entry for high-margin GLP-1 therapies could materially alter pharmacy mix and compress margins, reducing a growth engine for front-store and prescription profitability. This structural change would require strategic adjustments to pricing, sourcing and services.

Metro Inc. (MRU) vs. iShares MSCI Canada ETF (EWC)

Metro Inc. Business Overview & Revenue Model

Company DescriptionMetro Inc. operates as a retailer, franchisor, distributor, and manufacturer in the food and pharmaceutical sectors in Canada. It operates supermarkets and discount stores that provide fresh and grocery products, baked goods, prepared foods, meats, dairy products, fruits and vegetables, frozen foods, bakery products, and pastries, as well as Mediterranean and Middle Eastern products. As of September 25, 2021, the company operated a network of approximately 963 food stores under various banners, including Metro, Metro Plus, Super C, and Food Basics, Adonis, and Premiere Moisson as well as approximately 649 drugstores primarily under the Jean Coutu, Brunet, Metro Pharmacy, and Food Basics Pharmacy banners. It also manufactures generic drugs; and provides online grocery shopping services. Metro Inc. was founded in 1947 and is headquartered in Montréal, Canada.
How the Company Makes MoneyMetro Inc. generates revenue primarily through the sale of food and grocery products in its supermarkets and stores. The company's revenue model is based on a traditional retail framework, where it purchases products from suppliers at wholesale prices and sells them to consumers at retail prices, earning a margin on each sale. Key revenue streams include fresh food, packaged goods, and non-food items. Additionally, Metro Inc. benefits from private label products, which offer higher margins compared to branded products. The company also engages in promotional activities and loyalty programs to drive customer retention and increase sales. Significant partnerships with local suppliers and distributors enhance its product offerings and support its commitment to local sourcing, which helps attract customers and contribute to overall earnings.

Metro Inc. Earnings Call Summary

Earnings Call Date:Jan 27, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Apr 22, 2026
Earnings Call Sentiment Positive
The call conveyed a largely constructive operational and financial picture: revenue, online sales, adjusted EBITDA and adjusted EPS showed growth, the Toronto freezer issue has been resolved, and management reiterated continued investment and disciplined capital allocation (share buybacks, dividend increase, $550M CapEx plan). However, notable near-term headwinds remain, including the $21.6M freezer-related cost and lost sales, higher operating and financial costs, rising depreciation, sustained food inflation (especially meat), and competitive/square-footage pressures. On balance, the positive results and recovery from the distribution disruption outweigh the lowlights, with management emphasizing confidence in execution and long-term returns from recent investments.
Q1-2026 Updates
Positive Updates
Revenue Growth
Total sales reached $5.3 billion, up 3.3% year-over-year, with total food sales growth of 3.1% driven by new store openings and conversions.
Same-Store Sales Momentum
Food same-store sales grew 1.6% (1.9% when adjusted for a shifted pre-Christmas shopping day); pharmacy same-store sales rose 3.9% with prescription sales up 5.1% and front store sales up 1.3% (1.7% adjusted).
Adjusted Profitability Improvement
Adjusted EBITDA (excluding $21.6M of direct freezer costs) was $504.2 million, up 4.7% year-over-year and 9.5% of sales (an increase of 13 basis points versus Q1 2025).
Adjusted EPS Growth
Adjusted fully diluted net earnings per share were $1.16 versus $1.10 last year, an increase of 5.5% year-over-year; adjusted net earnings were $248.7 million, up 1.3%.
Strong Online and Private Label Performance
Online sales grew 25.8% in the quarter (driven by third-party marketplaces, ramped click-and-collect and new delivery in discount banners); private label sales continued to outperform national brands.
Capital Allocation and Shareholder Returns
Q1 share repurchases of 1 million shares for $98.7 million (average $98.72); Board declared a quarterly dividend of $0.475 (annualized $1.63), up 10.1% — marking the 32nd consecutive year of dividend growth with a payout of ~32% of last year's adjusted net earnings.
Investments and Growth Plans
Q1 CapEx was $61.9 million with FY26 CapEx expected to be ~ $550 million to continue investing in the retail network; opened three food stores in Q1 and added 88,600 sq. ft. (+0.4% of food retail square footage); plan for about a dozen discount stores in 2026.
Operational Recovery from Toronto Freezer Shutdown
Temporary shutdown of the frozen food distribution center in Toronto has been fully resolved and operations have resumed; contingency plan maintained supply across Ontario stores.
Negative Updates
Toronto Frozen DC Shutdown Costs and Sales Impact
Temporary shutdown of the Toronto frozen distribution center resulted in $21.6 million pretax ($15.9 million post-tax) of direct costs; management estimates ~30 basis points negative impact on same-store sales in the quarter and cited lost sales/margin on some frozen assortments.
Operating Expense Increase
Operating expenses totaled $557.6 million, up 5.5% year-over-year and 10.5% of sales (vs. 10.3% prior year); excluding $20.8 million of direct freezer costs, operating expenses rose 1.6% and represented 10.2% of sales.
Flatter Unadjusted EBITDA
Reported EBITDA was $482.6 million, up only 0.2% year-over-year and 9.1% of sales, showing muted unadjusted profitability due in part to the freezer issue and timing shifts.
Higher Net Financial Costs and Tax Rate
Net financial costs rose to $37.3 million from $30.7 million last year (partly due to lower interest receivable in the prior year and higher interest on net debt); effective tax rate increased to 25% from 18.2% last year driven by prior-year tax items and changes in tax holiday effects.
Increased Depreciation & Amortization
Depreciation and amortization rose to $143.6 million, up $10 million year-over-year, reflecting recent retail and supply chain investments (adds pressure on reported net earnings despite long-term benefits).
Inflationary and Competitive Pressures
Persistent food inflation—notably beef, poultry and grocery commodities—and an intense but 'rational' competitive environment with accelerating industry square footage create margin and promotional pressure; transaction counts were slightly down (offset by larger baskets).
Uncertainty on GLP-1 Genericization and Pharmacy Margins
Potential genericization of GLP-1 products (e.g., Ozempic) expected earlier in 2026 introduces uncertainty around future pharmacy margins and product mix timing; details on private label (Pro Doc) expansions remain undecided.
Company Guidance
Guidance highlights: Metro expects fiscal 2026 capital expenditures of approximately $550 million (Q1 CapEx was $61.9M vs $89.3M last year), plans roughly a dozen discount store openings in 2026 (three opened in Q1) and several major renovations, and grew net food retail space by 88,600 sq ft in Q1 (0.4% of network); the company repurchased 1.0 million shares for $98.7M (average $98.72) under its normal issuer bid as of Jan. 16, raised the quarterly dividend to $0.475 ($1.63 annual, +10.1%), representing about a 32% payout of last year’s adjusted net earnings, expects double‑digit cash‑on‑cash after‑tax returns from pharmacy supply‑chain automation, will consider gradual increases in leverage to support buybacks, and will report Q2 results on April 22, 2026.

Metro Inc. Financial Statement Overview

Summary
Solid, defensive fundamentals: steady revenue growth to ~$22.2B TTM with stable profitability (TTM gross margin ~19.9%, EBIT margin ~6.7%, net margin ~4.6%). Balance sheet leverage is moderate (debt-to-equity ~0.65) with attractive ROE (~13.9%), but total debt stepped up in the latest TTM snapshot. Cash generation remains strong (TTM FCF ~$1.14B), though cash conversion softened (OCF and FCF below net income) and recent FCF growth turned negative.
Income Statement
78
Positive
Metro shows steady top-line momentum, with revenue rising from ~$18.3B (2021) to ~$22.0B (2025 annual) and ~$22.2B in TTM (Trailing-Twelve-Months). Profitability is solid and fairly stable for the sector: gross margin is ~19.9% and net margin is ~4.6% in TTM, with EBIT margin ~6.7%. Strengths include consistent earnings power and resilient margins; the main weakness is that margins have not meaningfully expanded over time and growth appears to be moderating versus the stronger jump seen in 2023.
Balance Sheet
74
Positive
The balance sheet looks healthy with equity around ~$7.0B and total assets ~$14.9B in TTM (Trailing-Twelve-Months). Leverage is moderate: debt-to-equity sits around ~0.65 in TTM, down from the higher level seen in 2021 (~0.71), and returns on equity are attractive (~13.9% TTM), supporting the quality of earnings. The key risk is debt levels have moved higher in the latest TTM snapshot (total debt ~$6.26B vs ~$4.60B in the 2025 annual), which could reduce flexibility if costs rise or growth slows.
Cash Flow
68
Positive
Cash generation is a clear strength, with operating cash flow at ~$1.56B and free cash flow at ~$1.14B in TTM (Trailing-Twelve-Months). However, cash conversion has softened: operating cash flow is below net income in TTM (coverage ~0.79) and free cash flow is also below net income (about ~0.72x). Free cash flow growth is volatile, turning negative in TTM after positive growth in the 2025 annual period, which is the main watch item despite still-strong absolute cash flow.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue22.01B21.22B20.72B18.89B18.28B
Gross Profit4.37B4.18B4.08B3.78B3.65B
EBITDA2.08B1.99B2.00B1.79B1.74B
Net Income1.02B928.80M1.01B846.10M823.00M
Balance Sheet
Total Assets14.54B14.14B13.87B13.40B13.59B
Cash, Cash Equivalents and Short-Term Investments67.30M29.40M29.50M13.40M445.80M
Total Debt4.60B4.31B4.32B4.12B4.56B
Total Liabilities7.49B7.10B7.05B6.78B7.18B
Stockholders Equity7.03B7.02B6.80B6.60B6.40B
Cash Flow
Free Cash Flow1.16B1.06B867.60M847.80M969.90M
Operating Cash Flow1.61B1.56B1.46B1.37B1.49B
Investing Cash Flow-424.00M-471.50M-586.90M-492.70M-487.30M
Financing Cash Flow-1.15B-1.09B-861.80M-1.31B-998.30M

Metro Inc. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price95.62
Price Trends
50DMA
97.95
Negative
100DMA
96.21
Negative
200DMA
99.50
Negative
Market Momentum
MACD
-1.34
Positive
RSI
48.71
Neutral
STOCH
50.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MRU, the sentiment is Neutral. The current price of 95.62 is below the 20-day moving average (MA) of 96.22, below the 50-day MA of 97.95, and below the 200-day MA of 99.50, indicating a bearish trend. The MACD of -1.34 indicates Positive momentum. The RSI at 48.71 is Neutral, neither overbought nor oversold. The STOCH value of 50.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:MRU.

Metro Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$79.14B32.3621.51%1.52%4.21%14.03%
70
Outperform
C$38.95B26.8326.36%1.23%4.15%149.50%
69
Neutral
C$2.51B17.5718.69%3.27%2.08%9.31%
68
Neutral
C$11.09B16.4412.66%1.78%2.58%7.85%
66
Neutral
C$20.40B21.1314.48%1.50%3.71%12.40%
64
Neutral
C$53.47B41.38102.01%0.20%14.02%20.11%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:MRU
Metro Inc.
95.67
4.42
4.85%
TSE:L
Loblaw Companies
66.77
22.38
50.41%
TSE:DOL
Dollarama
193.39
53.58
38.33%
TSE:EMP.A
Empire Co Cl A NV
48.16
5.93
14.05%
TSE:NWC
North West
52.25
6.73
14.79%
TSE:WN
George Weston
101.74
28.02
38.01%

Metro Inc. Corporate Events

Executive/Board ChangesShareholder Meetings
Metro Shareholders Re-Elect Full Slate of Directors at 2026 Annual Meeting
Positive
Jan 28, 2026

Metro Inc. announced that all 11 management-nominated directors were elected to its board at the company’s January 27, 2026 annual general meeting of shareholders, each securing strong majority support in the votes cast. The reaffirmation of the full slate of directors underscores shareholder confidence in the company’s current leadership and strategic direction as it continues to consolidate its position as a major food and pharmacy player in Québec and Ontario, with implications for continuity in governance and stability for investors, employees and other stakeholders.

The most recent analyst rating on (TSE:MRU) stock is a Buy with a C$111.00 price target. To see the full list of analyst forecasts on Metro Inc. stock, see the TSE:MRU Stock Forecast page.

Business Operations and StrategyDividendsFinancial Disclosures
Metro Posts Higher Sales and Adjusted Earnings Despite Distribution Centre Shutdown
Positive
Jan 27, 2026

Metro Inc. reported first-quarter fiscal 2026 sales of $5.29 billion, up 3.3% year over year, driven by food same-store sales growth of 1.6% (1.9% adjusted for the Christmas shift), a 25.8% surge in online food sales, and pharmacy same-store sales up 3.9%. Net earnings fell 12.8% to $226.3 million, largely due to $21.6 million in direct costs linked to the temporary shutdown of its frozen food distribution centre in Toronto, but adjusted net earnings rose 1.3% to $248.7 million and adjusted EPS increased 5.5% to $1.16, indicating underlying earnings resilience. Operating income before depreciation and amortization was essentially flat at $482.6 million, with gross margin steady at 19.7% and operating expenses slightly higher as a share of sales because of the distribution centre disruption; excluding these exceptional costs, expense ratios would have improved. The company highlighted market share gains, strong performance of new discount stores and robust online growth despite persistent food inflation and operational challenges, and it raised its quarterly dividend by 10.1%, signaling confidence in its long-term growth strategy and financial strength.

The most recent analyst rating on (TSE:MRU) stock is a Buy with a C$115.00 price target. To see the full list of analyst forecasts on Metro Inc. stock, see the TSE:MRU Stock Forecast page.

Financial Disclosures
METRO Inc. Sets January 27 Date to Unveil Fiscal 2026 First-Quarter Results
Neutral
Jan 5, 2026

METRO Inc. announced it will publish its fiscal 2026 first-quarter results on January 27, 2026, followed by a conference call for investors and financial analysts hosted by President and CEO Eric R. La Flèche and Executive Vice President and CFO Nicolas Amyot. The call, which will include a question period for the financial community and listen-only access for journalists and the public, underscores the company’s continued emphasis on transparent communication with capital markets and stakeholders ahead of a key financial update for one of Canada’s largest food and pharmacy retailers.

The most recent analyst rating on (TSE:MRU) stock is a Buy with a C$113.00 price target. To see the full list of analyst forecasts on Metro Inc. stock, see the TSE:MRU Stock Forecast page.

Financial Disclosures
METRO Inc. Sets Date for Fiscal 2026 First-Quarter Results and Investor Call
Neutral
Jan 5, 2026

METRO Inc. announced that it will release its fiscal 2026 first-quarter results on January 27, 2026, followed by a conference call led by President and CEO Eric R. La Flèche and Executive Vice President and CFO Nicolas Amyot for investors and financial analysts, with a subsequent question period. The call, which will also be accessible in listen-only mode to journalists and the public and available as a replay until late February, underscores the company’s ongoing engagement with the financial community and offers stakeholders timely insight into its early 2026 performance in the competitive food and pharmacy retail market in Eastern Canada.

The most recent analyst rating on (TSE:MRU) stock is a Buy with a C$113.00 price target. To see the full list of analyst forecasts on Metro Inc. stock, see the TSE:MRU Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Metro Inc. Reports Growth in Fourth Quarter and Fiscal 2025 Results
Positive
Nov 19, 2025

Metro Inc. reported a 3.4% increase in sales for the fourth quarter of Fiscal 2025, reaching $5,108.7 million, with food and pharmacy same-store sales rising by 1.6% and 4.8%, respectively. Despite a temporary shutdown of its frozen food distribution center in Toronto, which negatively impacted net earnings by $22.5 million, the company achieved a 10.8% growth in adjusted fully diluted net earnings per share. For the fiscal year, sales grew by 3.7% to $22,006.7 million, and net earnings increased by 9.4% to $1,019.5 million. The company successfully opened new stores and converted others, aiming to continue its growth through strategic investments and strong execution.

The most recent analyst rating on (TSE:MRU) stock is a Buy with a C$110.00 price target. To see the full list of analyst forecasts on Metro Inc. stock, see the TSE:MRU Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 29, 2026